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Background: Recent studies have shown that nearly half of patients with acute decompensated heart failure (ADHF) are discharged with 
unresolved volume overload. To date, clinical assessment and serum measurement of B-type Natriuretic Peptide (BNP) are the primary means for 
gauging disease status in ADHF patients. The limitations of these tests in accurately assessing volume status may be contributing factors to the high 
readmission rates for heart failure patients. Bioelectrical impedance vector analysis (BIVA) provides a quick, inexpensive and noninvasive method for 
objectively evaluating total body hydration at the bedside. 
Methods: Patients were enrolled prospectively from a single-center to evaluate the prognostic utility of BIVA. BIVA was used to take serial 
measurements of hydration status in 45 patients admitted for ADHF. Patients were followed for 90 days after discharge for evaluation of the following 
primary endpoints: acute decompensation as diagnosed by the emergency department, hospital readmission for ADHF and/or all-cause mortality. 
Results: BIVA hydration analysis adds to the predictive power of BNP (Area under the curve of 0.780 vs. 0.848). Optimal cutpoint values of 77.2% 
by BIVA and BNP >640 pg/mL at discharge were determined using the Youden Index. Patients with BIVA hydration above the specified cutpoint 
(hyperhydration) at the time of discharge were more likely to have a diagnosed cardiac event within 90 days (HR = 10.772, p=0.04). Patients with 
an elevated BIVA hydration status above the cutpoint and a serum BNP above 640 pg/ml at discharge were at significantly increased risk for a 
cardiac event within 90 days (HR = 38.904, p = 0.001). 
Conclusions: Elevated BIVA hydration status at discharge is predictive of adverse events within 90 days while BIVA hydration values below the 
cutpoint were associated with a lower risk of adverse events after discharge. When considered along with BNP values, BIVA enhances the prognostic 
power of BNP in patients hospitalized with ADHF. These results suggest that the bedside measurement of hydration status with BIVA can help identify 
patients at high risk for adverse events after hospital discharge.
